McGuire Capital Advisors’s Amgen AMGN Stock Holding History

McGuire Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25K	Hold	69	–	–	0.01%	295
2026 Q1	$24.3K	Hold	69	–	–	0.02%	269
2025 Q4	$22.6K	Buy	+69	New	+$21.9K	0.01%	286

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

McGuire Capital Advisors's AMGN Position: Q2 2026 in Review

McGuire Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 69 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #295.

McGuire Capital Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

McGuire Capital Advisors held 69 shares of Amgen worth $25K as of Q2 2026.
McGuire Capital Advisors left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #295 holding.
McGuire Capital Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.